Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity
2016
Background: Sativex® (THC:CBD oromucosal spray) is indicated as add-on treatment for patients with moderate to severe multiple sclerosis (MS) spasticity. We aimed
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
19
References
11
Citations
NaN
KQI